The Bristol Myers Squibb Golden Ticket Contest at MBC BioLabs is a contest that awards two laboratory bench spots (comprised of one year of laboratory space for biomedical research at MBC BioLabs) to two innovative biotech start-ups pursuing research in the fields of oncology, hematology, immunology, cardiovascular disease or neuroscience that best meet the judging criteria of the Contest, or, in the sole discretion of the Judges, the one innovative biotech start-up that best meets the judging criteria will be awarded two laboratory bench spots at MBC BioLabs.

The Application for the Contest can be found below and must be completed in full and include an accurate description of the Applicant’s non-confidential research in the fields of oncology, hematology, immunology, cardiovascular disease or neuroscience, including for novel target identification, drug delivery, discovery technology platforms, or translational research and development. Applicant must legibly complete each section of the Application in English and may not exceed the space provided for in the Application. Applicants must also provide a non-confidential deck of no more than ten slides. Slides must address unmet medical need, solution, scientific principle, key data supporting the scientific principle, overview of business case, intellectual property, and highlight the team. All Applications become the property of Sponsor and cannot be acknowledged or returned.

The Application must also provide the name of the entity submitting the Application, the state of formation, a description of how it is eligible, and contact information including a point-person to communicate with BMS about the Contest.

All costs incurred by Applicants in submitting an Application and/or presenting at the Pitch Event, if selected, are the sole responsibility of Applicants.

Applications can be submitted through September 30, 2026 at 11:59 PM PDT.

The Judges for the Contest are the Bristol Myers Squibb Golden Ticket Committee, which consists of Bristol Myers Squibb employees who are qualified experts in their fields, including in the fields of scientific and/or medical research and business. Judges shall have authority to make decisions as to the Award Recipients.

Applications will be judged using the following criteria:

Judges will select a sub-set of the Applicants as Finalists. Finalists will be requested to present their concept as part of a Bristol Myers Squibb Pitch Event. All innovation event presentations will be non-confidential.

The Judges may contact Applicants for additional information. If so contacted, Applicant must respond to such request in order to remain eligible to have the opportunity to win the Award. The Decisions of the Judges shall be final and binding on all Applicants and cannot be challenged in any manner.

Applications and pitch decks and innovation event presentations may only contain non-confidential information about Applicant’s research.

Applications may not contain: material or information that violates or infringes a third party’s rights including but not limited to any privacy, publicity, trade secret, confidential or intellectual property rights including but not limited to patent, copyright or trademark.

BRISTOL MYERS SQUIBB SHALL HAVE NO LIABILITY FOR ANY PERSONAL INJURIES, DEATH, PROPERTY DAMAGE OR OTHER DAMAGES OR EXPENSES RESULTING FROM OR ARISING OUT OF RECIPIENT’S ACCEPTANCE OR USE OF THE AWARD.

By submitting an Application, Applicant agrees and acknowledges that all research disclosed in the Application and in connection with the Judging of the Application is non-confidential, will be reviewed and available to Bristol Myers Squibb and MBC BioLabs, may be available to a third parties, and may be publicly disclosed. As a result, Applicant waives all rights, claims and any cause of action Applicant against Bristol Myers Squibb and/or MBC BioLabs and their affiliated entities, advisors, agents, licensees, employees, contractors, directors and officers, related to any information disclosed in the Application and/or during the Judging process for the Contest, including but not limited to claims related to Applicant’s intellectual property, trade secrets or confidential information.